Crossmark

Budesonide in the first line treatment of patients with autoimmune hepatitis

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2021.11.012

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Olivas, Ignasi

Cobreros, Marina

Londoño, María-Carlota http://orcid.org/0000-0002-6533-1586
Díaz-González, Álvaro http://orcid.org/0000-0003-3610-2263
License Information

Text and Data Mining valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Budesonide in the first line treatment of patients with autoimmune hepatitis

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2021.11.012

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.